NWBS Northw.Bio Regs

    RNS Number : 3794A
  Northwest Biotherapeutics Inc
  31 July 2008
   

 For immediate release  31 JULY 2008

    Northwest Biotherapeutics
    ("NWBT" or the "Company")


    'Additional Listing'
    Amendment

    This is a replacement announcement for 'Holding in Company' RNS number 2471A posted on 30 July 2008.

    The heading 'Holding in Company' has been replaced with a new heading of 'Additional Listing'. There are two additional paragraphs
differentiating which shares are unrestricted and which are restricted of the 146,768 shares issued.

    Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), announced it has issued 146,768 shares of common stock $0.001 par
value, representing 0.3466% of the issued share capital. The shares were issued in fulfillment of a US$ 225,000 consideration for an option
to acquire certain assets of MithraGen Corporation and in fulfillment of the exercise of certain employee stock options.  

    122,190 of the shares issued at $0.001 par value are restricted and will be offered and sold outside the United States in reliance on
Regulation S. These shares relate to the acquisition of an option to acquire certain assets of MithraGen Corporation.  

    24,578 of the shares issued at $0.001 par value are unrestricted and will be eligible for settlement within CREST in the form of
depositary interests. These shares relate to the exercise of employee stock options.

    The shares were issued as follows: 754 shares on 17 April 2008 at a price of $2.267 per share; 122,190 shares on 17 June 2008 at $1.8414
per share and 23,824 shares on 27 June 2008 at $0.60 per share.

    Application has been made for the shares to be admitted to trading on AIM on 5 August 2008.

    For further information, please contact:

 Northwest Biotherapeutics
 Anthony P. Deasey, Chief Financial Officer                    +1 240-497-9024




 Buchanan Communications
 Lisa Baderoon (lisab@buchanan.uk.com) / Mary-Jane         +44 (0)20 7466 5000
 Johnson / Catherine Breen 

 Collins Stewart
 Adam Cowen/Tim Mickley                                    +44 (0)20 7523 8230


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
LISFKDKKPBKDAON

Northw.Bio Regs (LSE:NWBS)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Northw.Bio Regs (LSE:NWBS)
Historical Stock Chart
Von Jun 2023 bis Jun 2024